MIR30A Gene

HGNC Family Non-coding RNAs
Name microRNA 30a
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The encoded miRNA is one of five members of the miR-30 family of highly conserved miRNAs and participates in many cellular processes. It has additionally been implicated in the development of several types of cancer. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2017]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR‐30a is emerging as a multifaceted post‐transcriptional regulator that, in several cancers and stress settings, modulates autophagy to influence cell survival and therapeutic response. In tumor cells, miR‐30a directly targets key autophagy regulators such as beclin‑1, thereby suppressing autophagic activity and sensitizing cells to chemotherapy. In this context, forced expression of miR‐30a reduces beclin‑1 levels and autophagy‐induced survival, while its inhibition enhances autophagic flux and chemoresistance. In addition, miR‑30a is found incorporated in exosomes, which mediate intercellular communication of drug resistance and stress adaptation in both tumor cells and cardiomyocytes under hypoxia."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond autophagy regulation, miR‑30a plays a crucial role in restraining epithelial‐to‐mesenchymal transition (EMT) and metastasis across different tumor types. By targeting master regulators—including Snai1, vimentin, metadherin (MTDH), and other EMT‐promoting factors—miR‑30a suppresses the invasive, migratory, and self‐renewal capabilities of cancer cells in non–small cell lung cancer, breast cancer, colorectal carcinoma, thyroid, and prostate cancers. In many studies, reduced levels of miR‑30a are associated with advanced disease, higher metastatic potential and poor prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in modulating autophagy and EMT, miR‑30a regulates cell proliferation, apoptosis, and differentiation. Reduced miR‑30a expression enhances tumor‐initiating and mesenchymal traits—promoting oncogenic behaviors in contexts such as breast tumor‐initiating cells and pancreatic epithelial cells—whereas its restoration induces cell cycle arrest and apoptosis. Moreover, miR‑30a can modulate cellular metabolism by targeting enzymes like LDHA and has been implicated in neural functions via the regulation of BDNF, as well as in osteogenic differentiation through its control of bone‐related regulators."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe diagnostic and therapeutic potential of miR‑30a is further underscored in non‐malignant disease contexts. In the kidney, its expression in podocytes is protective by inhibiting Notch1 and p53 and thereby mitigating injury, while altered levels in plasma, urine, and exosomes are proposed as biomarkers for ischemic stroke, diabetic nephropathy, and focal segmental glomerulosclerosis. Notably, in ovarian serous adenocarcinoma, increased urinary miR‑30a‑5p correlates with early‐stage disease and lymphatic metastasis, suggesting its utility in non‐invasive diagnostics."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional studies have highlighted the versatility of miR‑30a in modulating therapeutic responses and cellular differentiation. For instance, miR‑30a is implicated in trastuzumab responsiveness in HER2‑positive breast cancer and in head and neck squamous cell carcinoma as a potential target for miRNA replacement therapy. In hepatocellular carcinoma, downregulation of miR‑30a‑3p contributes to tumor progression through its effects on oncogenic drivers, while altered placental miR‑30a‑3p expression has been linked to reduced IGF‑1 levels in preeclamptic pregnancies. Moreover, a newly identified p53/miR‑30a/ZEB2 regulatory axis plays a key role in controlling EMT and metastasis in triple‑negative breast cancer, and lncRNA MALAT1 has been shown to modulate miR‑30a levels during osteogenic differentiation via Runx2 regulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hua Zhu, Hao Wu, Xiuping Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autophagy (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/auto.9064"}], "href": "https://doi.org/10.4161/auto.9064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19535919"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19535919"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhenyou Zou, Linping Wu, Hanying Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.307405"}], "href": "https://doi.org/10.1074/jbc.M111.307405"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22157765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22157765"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Bing Zheng, Hua Zhu, Donghua Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.02.084"}], "href": "https://doi.org/10.1016/j.bbrc.2015.02.084"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25712526"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25712526"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ruida Xu, Shuzhong Liu, Haihong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.4497"}], "href": "https://doi.org/10.3892/or.2015.4497"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26708607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26708607"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wei-xian Chen, Xue-min Liu, Meng-meng Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0095240"}], "href": "https://doi.org/10.1371/journal.pone.0095240"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24740415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24740415"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yan Yang, Yingying Li, Xiao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-016-1387-2"}], "href": "https://doi.org/10.1007/s00109-016-1387-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26857375"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26857375"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "F Yu, H Deng, H Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.167"}], "href": "https://doi.org/10.1038/onc.2010.167"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20498642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20498642"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Regalla Kumarswamy, Giridhar Mudduluru, Paolo Ceppi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.26218"}], "href": "https://doi.org/10.1002/ijc.26218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21633953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21633953"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Chun-Wen Cheng, Hsiao-Wei Wang, Chia-Wei Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-012-2034-4"}], "href": "https://doi.org/10.1007/s10549-012-2034-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22476851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22476851"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "N Zhang, X Wang, Q Huo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.286"}], "href": "https://doi.org/10.1038/onc.2013.286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23851509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23851509"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jing Zhang, Chengwu Shen, Lin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.08.154"}], "href": "https://doi.org/10.1016/j.bbrc.2014.08.154"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25201727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25201727"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Myriem Boufraqech, Naris Nilubol, Lisa Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR30a inhibits LOX expression and anaplastic thyroid cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-2304"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-2304"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25488748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25488748"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhifang Liu, Long Chen, Xinchao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.12209"}], "href": "https://doi.org/10.1111/jcmm.12209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24447545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24447545"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "G-A Franzetti, K Laud-Duval, D Bellanger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.403"}], "href": "https://doi.org/10.1038/onc.2012.403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22986530"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22986530"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Wen-Fang Li, Hang Dai, Qin Ou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4456-1"}], "href": "https://doi.org/10.1007/s13277-015-4456-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26589417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26589417"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ming Zhong, Zhengqian Bian, Zhiyong Wu "}, {"type": "b", "children": [{"type": "t", "text": "miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000343362"}], "href": "https://doi.org/10.1159/000343362"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23486085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23486085"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Wei Wei, Yang Yang, Jian Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000447823"}], "href": "https://doi.org/10.1159/000447823"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27576787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27576787"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ivan Martinez, Demian Cazalla, Laura L Almstead, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-29 and miR-30 regulate B-Myb expression during cellular senescence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1017346108"}], "href": "https://doi.org/10.1073/pnas.1017346108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21187425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21187425"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Mugdha V Joglekar, Deepak Patil, Vinay M Joglekar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Islets (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/isl.1.2.9578"}], "href": "https://doi.org/10.4161/isl.1.2.9578"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21099261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21099261"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yu Liu, Jie Dong, Rong Mu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Rheum (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/art.37912"}], "href": "https://doi.org/10.1002/art.37912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23450709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23450709"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Ling Li, Lei Kang, Wei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2017.04.034"}], "href": "https://doi.org/10.1016/j.canlet.2017.04.034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28461244"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28461244"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Nikolaos Mellios, Hsien-Sung Huang, Anastasia Grigorenko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddn201"}], "href": "https://doi.org/10.1093/hmg/ddn201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18632683"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18632683"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Takanori Eguchi, Ken Watanabe, Emilio Satoshi Hara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0058796"}], "href": "https://doi.org/10.1371/journal.pone.0058796"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23533592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23533592"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Junnan Wu, Chunxia Zheng, Yun Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2012111101"}], "href": "https://doi.org/10.1681/ASN.2012111101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24029422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24029422"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Guangwen Long, Feng Wang, Huaping Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Neurol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2377-13-178"}], "href": "https://doi.org/10.1186/1471-2377-13-178"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24237608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24237608"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Guangwen Long, Feng Wang, Quanlu Duan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0050926"}], "href": "https://doi.org/10.1371/journal.pone.0050926"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23236408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23236408"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Wei Wang, Dong-Bin Li, Ru-Ying Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cerebrovasc Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000488365"}], "href": "https://doi.org/10.1159/000488365"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29627835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29627835"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Sanaa Eissa, Marwa Matboli, Miram M Bekhet "}, {"type": "b", "children": [{"type": "t", "text": "Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.06.018"}], "href": "https://doi.org/10.1016/j.biopha.2016.06.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27470555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27470555"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Wanfen Zhang, Changming Zhang, Huimei Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin J Am Soc Nephrol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2215/CJN.11561113"}], "href": "https://doi.org/10.2215/CJN.11561113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25107948"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25107948"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Jun Zhou, Guanghui Gong, Hong Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.3937"}], "href": "https://doi.org/10.3892/or.2015.3937"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25962395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25962395"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0031422"}], "href": "https://doi.org/10.1371/journal.pone.0031422"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22384020"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22384020"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Anthony D Saleh, Hui Cheng, Scott E Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-18-0716"}], "href": "https://doi.org/10.1158/1078-0432.CCR-18-0716"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30723145"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30723145"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "W Wang, H Lin, L Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Surg Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejso.2013.11.008"}], "href": "https://doi.org/10.1016/j.ejso.2013.11.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24290372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24290372"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Zi-Ru Niu, Tao Han, Xiao-Luan Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Obstet Gynecol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajog.2017.11.568"}], "href": "https://doi.org/10.1016/j.ajog.2017.11.568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29155142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29155142"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Alessandra di Gennaro, Valentina Damiano, Giulia Brisotto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-018-0103-x"}], "href": "https://doi.org/10.1038/s41418-018-0103-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29666469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29666469"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jiayong Yi, Dong Liu, Jian Xiao "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MALAT1 sponges miR-30 to promote osteoblast differentiation of adipose-derived mesenchymal stem cells by promotion of Runx2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Tissue Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00441-018-2963-2"}], "href": "https://doi.org/10.1007/s00441-018-2963-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30511267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30511267"}]}]}]}
Synonyms MIRN30A, MIR-30A
NCBI Gene ID 407029
API
Download Associations
Predicted Functions View MIR30A's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR30A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR30A's ARCHS4 Predicted Functions.

Functional Associations

MIR30A has 882 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 19 datasets.

Click the + buttons to view associations for MIR30A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR30A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR30A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR30A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR30A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR30A gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR30A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR30A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR30A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GAD Gene-Disease Associations diseases associated with MIR30A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR30A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR30A from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR30A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR30A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR30A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR30A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR30A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR30A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR30A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR30A protein from the Wikipathways Pathways 2014 dataset.